首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   268篇
  免费   11篇
  国内免费   26篇
儿科学   21篇
妇产科学   1篇
基础医学   21篇
口腔科学   1篇
临床医学   27篇
内科学   73篇
皮肤病学   5篇
神经病学   3篇
特种医学   60篇
外科学   16篇
综合类   17篇
预防医学   13篇
眼科学   2篇
药学   29篇
中国医学   2篇
肿瘤学   14篇
  2022年   4篇
  2020年   2篇
  2018年   6篇
  2015年   7篇
  2013年   5篇
  2012年   3篇
  2011年   4篇
  2010年   7篇
  2009年   11篇
  2008年   5篇
  2007年   15篇
  2006年   14篇
  2005年   13篇
  2003年   1篇
  2002年   7篇
  2001年   3篇
  2000年   4篇
  1999年   8篇
  1998年   18篇
  1997年   14篇
  1996年   11篇
  1995年   9篇
  1994年   14篇
  1993年   11篇
  1992年   4篇
  1991年   1篇
  1990年   7篇
  1989年   11篇
  1988年   10篇
  1987年   10篇
  1986年   3篇
  1985年   2篇
  1984年   4篇
  1983年   2篇
  1982年   11篇
  1981年   3篇
  1980年   3篇
  1979年   1篇
  1977年   1篇
  1976年   6篇
  1973年   1篇
  1961年   1篇
  1958年   1篇
  1957年   3篇
  1956年   4篇
  1955年   5篇
  1954年   4篇
  1949年   1篇
  1948年   3篇
  1930年   1篇
排序方式: 共有305条查询结果,搜索用时 15 毫秒
31.
Smith  WS; Sumnicht  GE; Sharpe  RW; Samuelson  D; Millard  FE 《Blood》1995,86(4):1301-1309
Sepsis is a common cause of morbidity and mortality. Neutrophils are the major defense against bacterial invasion, and granulocyte colony- stimulating factor (G-CSF) augments both neutrophil number and function. In our study, 160 rabbits were inoculated transtracheally with 0.5 mL of a solution containing 10(4) colony forming units per milliliter of Pasteurella multocida. Twenty-four hours later, chest x- rays and quantitative blood cultures demonstrated pneumonia and bacteremia. Therapy was then begun with penicillin G and either recombinant human G-CSF (rG-CSF; 5 to 8 micrograms/kg subcutaneously) or placebo every day for 5 days. Arterial blood gases and 23 other parameters of organ function were performed before inoculation and serially thereafter. All rabbits underwent histologic examination of organs at the time of septic death or when sacrificed on day 6. A total of 149 rabbits survived long enough to initiate therapy. A significant increase in leukocytes by day 4 was found in the rG-CSF-treated group. There was a trend towards improved survival in the rG-CSF group (77% v 67%; P = .13, n = 149). Analysis of pretreatment variables revealed sepsis-induced leukopenia (< or = 2,800/microL) as the only predictor of significantly improved survival with rG-CSF treatment (57% v 39%; P = .04, n = 73). The majority of the survival benefit occurred within the first 24 hours of treatment. This was before the time that a significant difference in mean white blood cell (WBC) count was observed between the study groups, making intravascular leukocytosis an unlikely explanation for the survival advantage in the rG-CSF group. No significant difference in laboratory variables reflecting organ function was demonstrated between the groups. Histologic grading of inflammation (0, normal, to 6, necrosis) in seven organs revealed that the surviving rabbits had mild but statistically significant increased inflammation in the liver, spleen, and noninoculated lung in the rG-CSF versus placebo groups (liver: 2.6 v 1.5, P < or = .0001; spleen: 3.2 v 2.3, P < or = .0001; and noninoculated lung: 2.9 v 2.5, P = .04). Administration of rG-CSF, in addition to penicillin G, in immune competent rabbits with gram-negative sepsis complicated by leukopenia significantly improved survival over antibiotics alone. The administration of rG-CSF in early sepsis for a short therapeutic duration was not associated with any clinically evident toxicity. Clinical trials using rG-CSF in septic patients with leukopenia are indicated.  相似文献   
32.
33.
1. Current evidence suggests that lysophosphatidylcholine (LPC), a component found in oxidized low-density lipoprotein (Ox-LDL), inhibits endothelium-dependent relaxation (EDR) mediated by endothelium-derived relaxing factor (EDRF) and endothelium-derived hyperpolarizing factor (EDHF). An objective of the present study was to characterize the roles of the different elements of EDR in LPC-induced impairment within the porcine coronary artery. Concomitantly, we sought to determine whether impairment of one component of EDR would increase the sensitivity of the endothelium to LPC. 2. Bradykini. (0.1 nmol/L-0.3 μmol/L) relaxed U46619 (30 nmol/L)-precontracted porcine coronary artery rings in a concentration-dependent manner. A reduction in the bradykinin-elicited response was observed in NG-nitro-L-arginine methyl ester (L-NAME; 300 μmol/L)- and ouabain (50 μmol/L)-treated rings. Pretreatment with LPC (20 μmol/L), which on its own had no effect on normal endothelial relaxation, resulted in further inhibition of EDRF- and EDHF-induced relaxations. 3. Our results demonstrate that EDRF and EDHF are the primary mediators of EDR in the porcine coronary artery. Our data also show that while a low concentration of LPC (20 μmol/L) does not impair EDR, it can evoke vascular dysfunction following blockade of either the effects of EDRF or EDHF. Therefore, these data suggest that the partially damaged vascular endothelium could be more sensitive to threshold levels of this atherogenic phospholipid.  相似文献   
34.
35.
金丝桃甙的合成研究   总被引:5,自引:0,他引:5  
金丝桃甙的合成研究蒋忠良,朱胄远,伍越环,王钟,周维善(中国科技大学化学系,合肥230026;中国科学院上海有机化学研究所,上海200032)金丝桃甙(Ⅰ)有抗过敏、解痉、抗胃溃疡和利尿等作用,且有显著止咳,降血压,降低胆固醇效果,无副作用(1~3)...  相似文献   
36.

Background  

In clinical trials, both unequal randomization design and sequential analyses have ethical and economic advantages. In the single-stage-design (SSD), however, if the sample size is not adjusted based on unequal randomization, the power of the trial will decrease, whereas with sequential analysis the power will always remain constant. Our aim was to compare sequential boundaries approach with the SSD when the allocation ratio (R) was not equal.  相似文献   
37.
38.
39.

Background  

The treatment of non-specific chronic low back pain is often based on three different models regarding the development and maintenance of pain and especially functional limitations: the deconditioning model, the cognitive behavioral model and the biopsychosocial model.  相似文献   
40.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号